PrEP chaos: how central Europe is suffering from inconsistent guidelines, random access, and healthcare stigma
South Africa to begin piloting injectable PrEP in early 2023
Large proportion of gay and bisexual migrants with HIV acquire the virus after arrival in France
Who is at risk of injectable treatment failure?
‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months
Increasing number of pregnancies in women who grew up with HIV
Survival prospects for older people with HIV plotted accurately by simple scoring system
After viral rebound, dolutegravir-based treatment more likely to suppress HIV
CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention
